Merrimack Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
MACK
CUSIP
590328209
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1 24.5 k $0
2024 Q4 2 24.5 k $371 k
2024 Q3 2 349 $0
2024 Q2 12 437 k $5.32 M
2024 Q1 77 9.38 M $138 M
2023 Q4 77 9.46 M $127 M
2023 Q3 70 8.47 M $104 M
2023 Q2 67 8.01 M $98.5 M
2023 Q1 58 7.40 M $91.0 M
2022 Q4 57 7.60 M $87.1 M
2022 Q3 46 8.01 M $30.0 M
2022 Q2 46 8.64 M $51.4 M
2022 Q1 45 7.90 M $49.4 M
2021 Q4 43 7.52 M $29.4 M
2021 Q3 41 7.68 M $37.1 M
2021 Q2 47 7.87 M $50.3 M
2021 Q1 49 7.93 M $49.8 M
2020 Q4 49 8.60 M $59.3 M
2020 Q3 42 6.99 M $27.7 M
2020 Q2 38 6.16 M $20.5 M
2020 Q1 41 6.46 M $13.9 M
2019 Q4 54 7.01 M $22.1 M
2019 Q3 50 6.60 M $29.7 M
2019 Q2 55 6.45 M $39.0 M
2019 Q1 57 5.43 M $37.7 M
2018 Q4 61 6.21 M $24.0 M
2018 Q3 69 6.71 M $35.8 M
2018 Q2 84 6.37 M $31.3 M
2018 Q1 85 7.86 M $63.3 M
2017 Q4 80 7.18 M $73.6 M
2017 Q3 74 6.64 M $96.5 M